risks of glp-1 Agonist: The Good, the Bad and the Ugly 🚨 As GLP-1 Use Explodes,

GLP-1 receptor agonists are no longer niche therapies

Kim DS, Choi HI, Wang Y, Luo Y, Hoffer BJ, Greig NH (2017) A new treatment strategy for Parkinsons disease through the gut-brain axis: the glucagon-like peptide-1 receptor pathway

Nausea, diarrhea, vomiting, constipation, and abdominal pain mostly early, mostly at each dose step-up, and mostly transient as the gut adapts

Dont buy a borrowed science NAD supplement

It actually has a history of being called the California drug as it can make you skinny and stupid As a side note, for the more easily triggered individuals, I am not saying people from California are stupid

If HbA1c doesn't improve after 3 months on medication, dosing or approach may need adjustment